检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈金明[1] 周海波[1] 张梁[1] 李伟华[2]
机构地区:[1]浙江大学医学院附属第二医院外科,浙江杭州310009 [2]福建省立医院外科,福建福州350000
出 处:《中国病理生理杂志》2005年第9期1758-1762,共5页Chinese Journal of Pathophysiology
摘 要:目的:探讨胃癌细胞中凋亡与增殖的细胞转换(AI/PI)的变化以及与生存的关系。方法:应用流式细胞仪,分别定量分析细胞的凋亡群体(AI)和增殖群体(PI);共聚焦显微镜对细胞增殖进行形态学观察;Kaplan-Mi-er法分析生存率。结果:肿瘤细胞凋亡与增殖经Pearson检验两者呈正相关,相关系数r=0.58(P<0.01)。在肿瘤细胞的临床病理特征中,AI/PI总体呈下降的趋势(与淋巴转移、远处转移相关,P<0.05)。胃癌细胞AI/PI的表达与肿瘤患者不同存活时间之间无显著差异。根据AI/PI的中位数值0.245,将胃癌细胞分为>0.245组和<0.245组。结果显示两组Kaplan-Meier生存曲线经Log-rank检验无显著差异(P>0.05)。共聚焦显微镜显示肿瘤组织中Ki-67高表达。结论:肿瘤细胞凋亡与增殖密切相关;随着肿瘤细胞的恶性进展,AI/PI总体呈下降的趋势;AI/PI不是评价预后的指标。AIM: To investigate the ratio of apoptotie index and proliferative index (AI/PI) in gastric cancer and their association with survival. METHODS: The apoptotic population and the proliferative population were quantitatively analyzed by flow cytometry. The proliferative cells were identified by confocal microscope and Kaplan - Meier method was used to analyze survival. ~TS : AI and PI were strongly correlated with a Pearson coefficient of 0.58 ( P 〈 0.01 ). A stepwise decrease trend in AI/PI was noted in clinical pathological variables, including lymph node metastasis and beyond metastasis ( P 〈 0.05 for each). No statistically significant difference in AI/PI expression based on different survival times was observed. Using the median AI/PI of 0.245, the cells were divided into two groups (greater than and less than the median AI/PI). Using Kaplan - Meier survival curves and the Log - rank test, no statistic difference was found in two groups. The high expression of Ki - 67 in tumor was found by confocal microscope. CONCLUSION: AI and PI are. significantly correlated. A stepwise decrease trend in AI/PI may exist in tumor progression. AI/PI mav not he good as a prognostic factor for cancer evaluation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:52.14.157.158